Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1

Journal of Clinical Investigation

Volumn 101, Issue 1, 1998, Pages 145-152

  Jong, Miek C ^a   Gijbels, Marion J J ^b   Dahlmans, Vivian E H ^a   Van Gorp, Patrick J J ^b   Koopman, Sietse Jan ^c   Ponec, Maria ^c   Hofker, Marten H ^b   Havekes, Louis M ^a,c  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apolipoprotein C; Hypertriglyceridemia; Sebaceous glands; Sebum production; Triglycerides

Indexed keywords

APOLIPOPROTEIN C1; CHOLESTEROL; FATTY ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYPERKERATOSIS; HYPERLIPIDEMIA; LIPOGENESIS; LIPOPROTEIN METABOLISM; MALE; MEIBOMIAN GLAND; NONHUMAN; PRIORITY JOURNAL; SEBUM SECRETION; SKIN ATROPHY; SUBCUTANEOUS FAT; TRANSGENIC MOUSE;

EID: 0031985353     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI791     Document Type: Article

References (36)

1. Smit, M., E. van der Kooij-Meijs, R.R. Frants, L.M. Havekes, and E.C. Klasen. 1988. Apolipoprotein gene cluster on chromosome 19. Definite localization of the APOC2 gene and the polymorphic Hpa I site associated with type III hyperlipoproteinemia. Hum. Genet. 78:90-93.
2. Lauer, S.J., D. Walker, N.A. Elshourbagy, C.A. Reardon, B. Levy-Wilson, and J.M. Taylor. 1988. Two copies of the human apolipoprotein C1 gene are linked closely to the apolipoprotein E gene. J. Biol. Chem. 263:7277-7286.
3. Shachter, N.S., Y. Zhu, A. Walsh, J.L. Breslow, and J.D. Smith. 1993. Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus. J. Lipid Res. 34:1699-1707.
4. Simonet, W.S., N. Bucay, S.J. Lauer, and J.M. Taylor. 1993. A far-down-stream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C1 genes in transgenic mice. J. Biol. Chem. 268: 8221-8229.
5. Simonet, W.S., N. Bucay, R.E. Pitas, S.J. Lauer, and J.M. Taylor. 1991. Multiple tissue-specific elements control the apolipoprotein E/C-II gene locus in transgenic mice. J. Biol. Chem. 266:8651-8654.
6. van Ree, J.H., M.H. Hofker, W.J.A.A. van den Broek, J.M.A. van Deursen, H. van der Boom, R.R. Frants, B. Wieringa, and L.M. Havekes. 1995. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice. Biochem. J. 305:905-911.
7. Jong, M.C., J.H. van Ree, V.E.H. Dahlmans, R.R. Frants, M.H. Hofker, and L.M. Havekes. 1996. Reduced very low density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice. Biochem. J. 321:445-150.
8. Jong, M.C., V.E.H. Dahlmans, P.J.J. van Gorp, M.L. Breuer, M.J.T.M. Mol, A. van der Zee, R.R. Frants, M.H. Hofker, and L.M. Havekes. 1996. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1. Arterioscler. Thromb. Vasc. Biol. 16:934-940.
9. Shachter, N.S., T. Ebara, R. Ramakrishnan, G. Steiner, J.L. Breslow, H.N. Ginsberg, and J.D. Smith. 1996. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein C1. J. Clin. Invest. 98:846-855.
10. Jong, M.C., V.E.H. Dahlmans, P.J.J. van Gorp, K. Willems van Dijk, M.L. Breuer, M.H. Hofker, and L.M. Havekes. 1996. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J. Clin. Invest. 98:2259-2267.
11. Soutar, A.K., C.W. Garner, H.N. Baker, J.T. Sparrow, R.L. Jackson, A.M. Gotto, Jr, and L.C. Smith. 1975. Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin:cholesterol acyltransferase. Biochemistry. 14:3057-3064.
12. Zannis, V.I., J. McPherson, G. Goldberger, S.U. Karathanasis, and J.L. Breslow. 1984. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J. Biol. Chem. 259:5495-5499.
13. Church, G.M., and W. Gilbert. 1984. Genome sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 81:1991-1995.
14. Fort, P.I., L. Marty, M. Piechaczyk, S.E. Sabrouty, C. Dani, P. Jeanteur, and J.M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431-1442.
15. Koopmans, S.J., S.F. de Boer, H.C.M. Sips, J.K. Radder, M. Frölich, and H.M.J. Krans. 1991. Whole body and hepatic insulin action in normal, starved and diabetic rats. Am. J. Physiol. 260:825-832.
16. Bligh, E.G., and W.J. Dyer. 1959. A rapid method for total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
17. Ponec, M., A. Weerheim, J. Kempenaar, A.M. Momaas, and D.H. Nugteren. 1988. Lipid composition of cultured human keratinocytes in relation to their differentiation. J. Lipid Res. 29:949-961.
18. Stewart, M.E., and D.T. Downing. 1991. Chemistry and function of mammalian sebaceous lipids. Adv. Lipid Res. 24:263-301.
19. Wilkinson, D.I., and M.A. Karasek. 1966. Skin lipids of a normal and a mutant (asebic) mouse strain. J. Investis. Dermatol. 47:449-155.
20. Tiffany, J.M. 1987. The lipid secretion of the meibomian glands. Adv. Lipid Res. 22:1-62.
21. Nicolaides, N., and E.C. Santos. 1985. The di- and triesters of the lipids of steer and human meibomian glands. Lipids. 20:454-467.
22. Pochi, P.E., D.T. Downing, and J.S. Strauss. 1970. Sebaceous gland response in man to prolonged total caloric deprivation. J. Investis. Dermatol 55: 303-309.
23. Downing, D.T., J.S. Strauss, and P.E. Pochi. 1972. Changes in skin surface lipid composition induced by severe caloric restriction in man. Am. J. Clin. Nutr. 25:365-367.
24. Randle, P.J., P.B. Garland, and C.N. Hales. 1963. The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances in diabetus mellitus. Lancet. 1:785-789.
25. Weinstock, P.H., C.L. Bisgaier, K. Aalto-Setälä, H. Radner, R. Ramakrishnan, S. Levak-Frank, A.D. Essenburg, R. Zechner, and J.L. Breslow. 1996. Severe hypertriglyceridemia. reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. J. Clin. Invest. 96:2555-2568.
26. Frykman, P.K., M.S. Brown, T. Yamamoto, J.L. Goldstein, and J. Herz. 1995. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92:8453-8457.
27. Yamamoto, T., S. Takahashi, J. Sakai, and Y. Kawarabayasi. 1993. The very low density lipoprotein receptor. Trends Cardiovasc. Med. 3:144-148.
28. Yamamoto, T., A. Hoshino, S. Takahashi, Y. Kawarabayasi, H. Iijima, and J. Sakai. 1995. The role of the very low density lipoprotein receptor in the metabolism of plasma lipoproteins containing ApoE. Ann. NY Acad. Sci. 748: 217-225.
29. Jong, M.C., V.E.H. Dahlmans, P.J.J. van Gorp, K. Willems van Dijk, S.-J. Koopmans, L. Chan, M.H. Hofker, and L.M. Havekes. 1996. The binding of VLDL to the VLDL receptor is inhibited by an excess of apoC1. Cir. Suppl. 94: 4081. (Abstr.)
30. Gates, A.H., and M.A. Karasek. 1965. Hereditary absence of sebaceous glands in the mouse. Science. 148:1471-1473.
31. Wilkinson, D.I., and M.A. Karasek. 1966. Skin lipids of a normal and a mutant (asebic) mouse strain. J. Investis. Dermatol. 47:449-455.
32. Gates, A.H., F.D. Arundell, and M.A. Karasek. 1969. Hereditary defect of the pilosebaceous unit in a new double mutant mouse. J. Investis. Dermatol. 52:115-118.
33. Brown, W.R., and M.H. Hardy. 1988. A hypothesis on the cause of chronic epidermal hyperproliferation in asebia mice. Clin. Exp. Dermatol. 13: 74-77.
34. Green, M.C. 1981. Catalog of mutant genes and polymorphic loci. In Genetic Variants and Strains of the Laboratory Mouse. M.C. Green, editor. Fisher, New York. 16.
35. Pinheiro, M., N. Freire-Maia, E.A. Chautard-Freire-Maia, L.M.B. Araujo, and B. Liberman. 1983. AREDYLD: a syndrome combining an acrorenal field defect, ectodermal dysplasia, lipoatrophic diabetes and other manifestations. Am. J. Med. Genet. 16:29-33.
36. Breslau-Siderius, E.J., J. Toonstra, J.A. Baart, H.P.F. Koppeschaar, J.A. Maassen, and F.A. Beemer. 1992. Ectodermal dysplasia, lipoatrophy, diabetes mellitus, and amastia: a second case of the AREDYLD syndrome. Am. J. Med. Genet. 44:374-377.